A bill to amend the Controlled Substances Act relating to controlled substance analogues.
Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act
(Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Introduced in Senate
Read twice and referred to the Committee on the Judiciary.
Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line